Literature DB >> 28410757

Outpatient desensitization in selected patients with platinum hypersensitivity reactions.

David M O'Malley1, Monica Hagan Vetter2, David E Cohn2, Ambar Khan3, John L Hays4.   

Abstract

Platinum-based chemotherapies are a standard treatment for both initial and recurrent gynecologic cancers. Given this widespread use, it is important to be aware of the features of platinum hypersensitivity reactions and the subsequent treatment of these reactions. There is also increasing interest in the development of desensitization protocols to allow patients with a history of platinum hypersensitivity to receive further platinum based therapy. In this review, we describe the management of platinum hypersensitivity reactions and the desensitization protocols utilized at our institution. We also describe the clinical categorizations utilized to triage patients to appropriate desensitization protocols.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carboplatin; Desensitization; Hypersensitivity reactions

Mesh:

Substances:

Year:  2017        PMID: 28410757     DOI: 10.1016/j.ygyno.2017.03.015

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin Hypersensitivity.

Authors:  Salvador Alonso Martinez; Neil H Segal; Andrea Cercek; Rona Yaeger; Zsofia Stadler; Nancy E Kemeny; Maliha Nusrat; Armin Shahrokni; Louise Connell; Leonard B Saltz
Journal:  Clin Colorectal Cancer       Date:  2022-01-19       Impact factor: 4.035

2.  A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer.

Authors:  Katherine LaVigne; David M Hyman; Qin C Zhou; Alexia Iasonos; William P Tew; Carol Aghajanian; Vicky Makker; Martee L Hensley; Jason Konner; Rachel N Grisham; Nicholas Cangemi; Krysten Soldan; David R Spriggs; Paul J Sabbatini; Roisin E OʼCearbhaill
Journal:  Int J Gynecol Cancer       Date:  2018-07       Impact factor: 3.437

3.  Current situation of carboplatin desensitisation protocols in the hospitals of Spain.

Authors:  Rocío Vázquez Sánchez; Javier Sánchez-Rubio Ferrández; Damián Córdoba-Díaz; Manuel Córdoba-Díaz; Raúl Díez-Fernández; Teresa Molina-Garcia
Journal:  Eur J Hosp Pharm       Date:  2019-02-20

4.  Successful resuscitation after cardiac arrest secondary to carboplatin infusion: A case report.

Authors:  Madushka Y De Zoysa; Nicole A Nakamaru; Samantha B Kaiser; Marcia A Ciccone; Laila I Muderspach; Koji Matsuo
Journal:  Gynecol Oncol Rep       Date:  2017-12-14

5.  Does Carboplatin Rapid Desensitization Change Its Adverse Drug Reactions Other than Hypersensitivity and Efficacy in Patients With Ovarian Cancer?

Authors:  Han Ki Park; Soo Jung Lee; Sujeong Kim; Jong Myung Lee; Dae Gy Hong
Journal:  Allergy Asthma Immunol Res       Date:  2020-11       Impact factor: 5.764

Review 6.  Hypersensitivity Reactions to Platinum Agents and Taxanes.

Authors:  Lulu R Tsao; Fernanda D Young; Iris M Otani; Mariana C Castells
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-02       Impact factor: 10.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.